GASTRIC (STOMACH) CANCER

This study tests a new treatment called RAK cell therapy, made from human umbilical cord blood, for people with advanced stomach cancer that has spread or come back after standard treatment. The goal is to see if it is safe and helps patients live longer without their cancer grow…

This study looks at people with esophageal or stomach cancer that has spread to only a few spots in the body. After 4 months of standard chemotherapy, some will get local treatment (surgery or radiation) right away, while others will have 4 more months of chemo first. The goal is…

This early-stage trial tests a new drug called DA 3501 in adults with advanced stomach or pancreatic cancer that has a specific marker (CLDN18.2). The main goals are to find the safest dose and see if the drug can shrink tumors. Participants receive the drug every three weeks and…

This study tests a new drug called TCC1727 combined with other cancer treatments (benmelstobart, olaparib, or topotecan) in people with advanced solid tumors like lung, stomach, endometrial, or melanoma. The goal is to find the safest and most effective dose and see if the combin…

This study is testing whether adding a drug called fruquintinib to standard chemotherapy and trastuzumab can help control advanced HER2-positive stomach or gastroesophageal junction cancer. It is for people who have not had prior treatment for their metastatic disease. The goal i…

This study is testing a new way to screen for stomach cancer using a stool (fecal) sample and a risk questionnaire. Researchers want to see if this simple, non-invasive test can catch cancer earlier than current methods. About 15,000 adults aged 40 and older will take part. This …

This study tests whether using virtual reality (VR) can reduce severe belly pain and improve daily life in people with digestive tract cancers. 360 participants will be randomly assigned to one of three groups: skills-based VR, distraction VR, or a sham VR. The goal is to see if …

This study tests whether the drug riluzole can prevent memory and thinking problems (often called 'chemo brain') in people receiving chemotherapy for various cancers. About 24 adults with breast, lung, or other cancers will receive either riluzole or a placebo during their chemo.…

This study collects tissue and blood samples from people with stomach or esophageal cancer, as well as those at high inherited risk, to learn how genes and proteins contribute to these cancers. The goal is to better understand the disease, not to test a new treatment. About 100 p…

This study aims to describe the features of gastric cancer in 1,000 patients in Algeria, including their demographics, risk factors, symptoms, and how the disease is diagnosed and treated. Researchers will collect data from medical records and follow patients over time to underst…

This study follows 3000 adults aged 40 and older who carry H. pylori bacteria in their stomach. Researchers want to see if people with certain high-risk subtypes of the bacteria are more likely to develop stomach cancer or precancerous changes over 3 to 10 years. Participants wil…